In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...

Cancer vaccines play a very important role in helping us build our immunity and fight off tum our cells, however, not all ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease ...

Phase 1 trial of a pancreatic cancer vaccine targeting mutant KRAS shows strong immune responses, extended survival, and ...

DENVER — Early data for a new vaccine for pancreatic cancer is generating some hope among patients, researchers and doctors.

A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...

Zev A. Wainberg, MD, discussed the significance of the immune response signals in a phase 1 trial of an amphiphile vaccine for pancreatic cancer.

An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...

The ELI-002 2P vaccine uses peptides to train the immune system to spot and destroy cells with KRAS mutations.

Across the land, rainbow crosswalks face orders to erase ‘asphalt art’ Bondi announces nearly 200 arrests 'and counting' as ...